Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

Gridelli Cesare; Ascierto Paolo A.; Barberis Massimo C. P.; Felip Enriqueta; Garon Edward B.; Obrien Mary; Senan Suresh; Casaluce Francesca; Sgambato Assunta; Papadimitrakopoulou Vali; De Marinis Filippo

首页> 外文期刊>Expert opinion on biological therapy >Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

【24h】

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

机译：非小细胞肺癌的免疫治疗：意大利胸腔肿瘤协会国际专家小组会议的报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: The potential long term survival gain, related to immune adaptability and memory, the potential activity across multiple tumour types through targeting the immune system, and the opportunity for combinations offered by the unique mechanism of actions and safety profile of these new agents, all support the role of immunotherapy in the cancer treatment pathway or paradigm.

机译：简介：与免疫适应性和记忆力有关的潜在长期存活收益，通过靶向免疫系统在多种肿瘤类型中的潜在活性以及这些新药独特的作用机制和安全性提供的组合机会，所有这些支持免疫疗法在癌症治疗途径或范例中的作用。

著录项

来源
《Expert opinion on biological therapy》 |2016年第12期|共11页
作者
Gridelli Cesare; Ascierto Paolo A.; Barberis Massimo C. P.; Felip Enriqueta; Garon Edward B.; Obrien Mary; Senan Suresh; Casaluce Francesca; Sgambato Assunta; Papadimitrakopoulou Vali; De Marinis Filippo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Combination therapies; immune checkpoint inhibitors; immune-related toxicity; nivolumab; pembrolizumab; programmed death-1 (PD-1);

机译：联合疗法;免疫检查点抑制剂;免疫相关毒性;诺和单抗;派姆单抗;程序性死亡1（PD-1）;

相似文献

外文文献
中文文献
专利

1. Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology [J] . Gridelli Cesare, Ascierto Paolo A., Barberis Massimo C. P., Expert opinion on biological therapy . 2016,第12期

机译：非小细胞肺癌的免疫治疗：意大利胸腔肿瘤协会国际专家小组会议的报告
2. Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology [J] . Gridelli Cesare, Baas Paul, Barlesi Fabrice, Clinical lung cancer . 2018,第4期

机译：非小细胞肺癌中的二线治疗方案：意大利胸肿瘤学协会的国际专家小组会议的报告
3. The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology [J] . Gridelli Cesare, Besse Benjamin, Brahmer Julie Renee, Clinical lung cancer . 2016,第3期

机译：Nivolumab在非小细胞肺癌二线治疗中的作用不断演变：我们治疗算法的新基石。意大利胸腔肿瘤学会国际专家小组会议的结果
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Effect of Antibiotics on Immunotherapy Response in Patients with Non-small Cell Lung Cancer [D] . Esmail, Fatema M. 2019

机译：抗生素对非小细胞肺癌患者免疫疗法反应的影响
6. Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology [O] . Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, 2017

机译：非小细胞肺癌免疫治疗的预测性生物标志物：意大利胸腔肿瘤协会专家小组会议的结果
7. Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology [O] . Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, 2017

机译：非小细胞肺癌免疫疗法预测生物标志物：意大利胸肿瘤学协会专家组会议的结果

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

摘要

著录项

相似文献

相关主题

期刊订阅